From Sensing to Computing: NVision’s Molecular Qubits

Forbes profiled NVision’s $55 million Series B financing round, led by Abbott, and the company’s efforts to scale its quantum-enhanced metabolic imaging platform. The article highlights how POLARIS boosts MRI signals by more than 10,000 times, enabling researchers to visualize tumor metabolism and assess treatment response within days rather than months. It also outlines NVision’s plans to expand to 20 research centers worldwide and apply its molecular quantum technology to drug discovery and development.

Read the full article on Forbes.com ↗

‍

SWR profiled NVision’s path from quantum-enhanced MRI to quantum computing, highlighting how research into molecules for metabolic imaging led to an unexpected discovery: a new type of molecular qubit. The article explores how molecular qubits could enable a stable, scalable approach to quantum computing.

Watch the full segment

‍